Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Ponesimod in Patients With Relapsing-remitting Multiple Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01093326
Recruitment Status : Active, not recruiting
First Posted : March 25, 2010
Last Update Posted : September 4, 2019
Sponsor:
Information provided by (Responsible Party):
Actelion

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 15, 2021
Estimated Study Completion Date : December 15, 2021